Medtronic(MDT)
Search documents
Voluntary recall notifying Medtronic insulin pump users of potential risks of shortened pump battery life
Prnewswire· 2024-10-04 10:45
Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue GALWAY, Ireland, Oct. 4, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to c ...
Reasons to Retain Medtronic Stock in Your Portfolio Now
ZACKS· 2024-10-01 15:20
Medtronic plc’s (MDT) growth is backed by remarkable progress within the Neurosurgery Portfolio. The company’s continuous efforts to capture several growth markets look impressive. Meanwhile, headwinds from adverse foreign exchange effects pose a challenge to Medtronic’s operations. Mounting costs and expenses due to geopolitical conditions also add to the worry.In the past year, this Zacks Rank #3 (Hold) stock has risen 15.6% compared with the industry’s 24.2% growth. The S&P 500 composite has witnessed a ...
Positive Trial Outcome for PulseSelect PFA Likely to Boost MDT Stock
ZACKS· 2024-09-30 13:15
Medtronic plc (MDT) has shared late-breaking clinical trial results for its PulseSelect Pulsed Field Ablation (“PFA”) system, demonstrating a high rate of durable lesion formation in treating atrial fibrillation (Afib). The findings were presented at the Asia Pacific Heart Rhythm Society meeting held in Sydney, Australia.The widespread adoption of PulseSelect also continues, with more than 10,000 cases having been performed worldwide.Predicting MDT Stock Movement Following the NewsAfter the announcement, Me ...
New clinical data demonstrate excellent lesion durability with PulseSelect™ Pulsed Field Ablation System in real-world setting as approvals and adoption expand globally
Prnewswire· 2024-09-27 23:00
APHRS: New data confirm robust long-term durability and highly efficient procedure performed without fluoroscopySuccessful launch in Japan follows recent reimbursement approval Approvals across APAC including China and Australia broaden reach for patientsGALWAY, Ireland and SYDNEY, Sept. 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the presentation of clinical study results demonstrating a high rate of durable lesion formation for the PulseSe ...
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
ZACKS· 2024-09-27 14:47
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores.W ...
Federated Hermes, Inc. launches MDT Mid Cap Growth Collective Investment Fund
Prnewswire· 2024-09-26 20:17
Newest MDT product aims to meet growing demand for retirement products PITTSBURGH, Sept. 26, 2024 /PRNewswire/ -- Federated Hermes, Inc. (NYSE: FHI), a global leader in active investment management, today announced the launch of the Federated Hermes MDT Mid Cap Growth Collective Investment Fund, a strategy for qualified retirement plan investors. The fund pursues capital appreciation by investing in a diversified portfolio of US mid-cap growth companies.The Federated Hermes MDT stock-selection process utili ...
MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership
ZACKS· 2024-09-26 15:05
At the North American Spine Society's 39th Annual Meeting in Chicago, Medtronic plc (MDT) commercially launched several software, hardware and imaging innovations to advance its AiBLE spine technology ecosystem. In addition, the company announced a partnership with Siemens Healthineers to explore opportunities for expanding access to cutting-edge pre and post-operative imaging technologies for spine care. MDT Stock's Trend Following the News After the announcement, shares of MDT dipped 0.4% to close at $89. ...
Medtronic expands AiBLE™ spine surgery ecosystem with new technologies and Siemens Healthineers partnership
Prnewswire· 2024-09-25 12:00
GALWAY, Ireland and CHICAGO, Sept. 25, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today at the North American Spine Society (NASS) 39th Annual Meeting in Chicago the commercial launch of several software, hardware, and imaging innovations. These enhancements are designed to advance AiBLE™, the Medtronic smart ecosystem of innovative navigation, robotics, data and AI, imaging, software and implants that enable more predictable outcomes in spine and cra ...
Medtronic (MDT) Up 0.7% Since Last Earnings Report: Can It Continue?
ZACKS· 2024-09-19 16:31
A month has gone by since the last earnings report for Medtronic (MDT) . Shares have added about 0.7% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Medtronic due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Medtronic Q1 Earnings, Revenues Top Estimates, Margins D ...
Medtronic: An Undervalued Stock With Durable Competitive Advantages
Seeking Alpha· 2024-09-16 13:00
CottonCandyClouds/iStock via Getty Images Medtronic PLC (NYSE:MDT) is a global developer and manufacturer of medical devices for chronic diseases. Founded in 1949, Medtronic is now a $111 billion (by market cap) healthcare behemoth that employs 95,000 people. The company reports results across four segments: Cardiovascular, 37% of FY 2023 revenue; Neuroscience, 29%; Medical Surgical, 27%; and Diabetes, 7%. Medtronic's product portfolio is comprised of a variety of life-saving and life-improving medical devi ...